MRNA
Moderna, Inc.
Stock
$190.01+1.07 (+0.57%)Close Oct 2, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $5.1B | $5.8B | $7.0B | $8.6B | $9.9B | $10.7B | $4.6B | $1.1B | $1.5B | $756M | $50M |
| Inventory | $280M | $153M | $117M | $202M | $949M | $1.4B | $47M | $0 | — | — | — |
| Current assets | $5.8B | $6.5B | $8.1B | $10.3B | $13.4B | $16.1B | $6.3B | $1.1B | $1.6B | $783M | — |
| Goodwill | $52M | $52M | $52M | $52M | $0 | — | — | — | — | — | — |
| Intangible assets | $109M | $45M | $40M | $44M | $0 | — | — | — | — | — | — |
| Total assets | $11.0B | $12.3B | $14.1B | $18.4B | $25.9B | $24.7B | $7.3B | $1.6B | $2.0B | $1.1B | — |
| Current liabilities | $2.5B | $2.0B | $2.2B | $3.0B | $4.9B | $9.1B | $4.4B | $143M | $223M | $191M | — |
| Long-term debt | $591M | $590M | $0 | — | — | — | — | — | — | — | — |
| Total liabilities | $4.2B | $3.7B | $3.2B | $4.6B | $6.7B | $10.5B | $4.8B | $415M | $432M | $459M | — |
| Shareholders' equity | $6.8B | $8.7B | $10.9B | $13.9B | $19.1B | $14.1B | $2.6B | $1.2B | $1.5B | −$551M | −$335M |
| Shares outstanding | 399.2M | 394.9M | 385.8M | 382.1M | 386.3M | 402.9M | 399.8M | 368.6M | 329.0M | — | — |
| Current ratio | 2.29 | 3.29 | 3.67 | 3.42 | 2.73 | 1.76 | 1.43 | 7.89 | 7.02 | 4.09 | — |